The Governance RegisterEdition 2026 · Compiled 12th July 2026

Sitryx Therapeutics Limited

Company 10366466 Active

Connected board network

The connection graph needs a free account.

This company's record is public. The network of who else its directors govern is compiled from the registers by us, and an account keeps it out of bulk scrapers.

Sign in, free

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

11 directors on the board

5.8y median 6.3y
average tenure
9.4y
longest tenure

Directors past 6 years

First-time vs portfolio directors

First-time (7)

Portfolio (4)

0
also govern a charity

Left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 10Finance 2

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Several long-serving directors could step down together
  • Narrow spread of sectors across the board

Where to look Suggested search: succession planning for long-tenured seats; directors from a wider range of sectors.

Related organisations iRelated organisationsTwo groups, both deterministic from public records. Related organisations share two or more directors with this board - a real structural link, such as a subsidiary or group company. Connected through a shared director share exactly one person - a genuine connection, but not the same group.

Related organisations

Connected through a shared director

Deterministic, from public records.

Company details

Number10366466
StatusActive
TypePrivate Limited Company
Incorporated08/09/2016
Address101 BELLHOUSE BUILDING MAGDALEN CENTRE, THE OXFORD SCIENCE PARK, OXFORD, OX4 4GA
Accounts next due30/09/2027
Accounts last made up31/12/2025

Industry (SIC)

72110 - Research and experimental development on biotechnology

Ownership - persons with significant control (1)

  • Professor Houman Ashrafian ceased 2018 British
    ownership of shares 75-100% voting rights 25-50%

Officers (20)

Show 9 former officers

Directors and officers on the Companies House record, current and former.

Report an error in this record - let us know.